Compare LSE & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSE | YI |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Retail-Drug Stores and Proprietary Stores |
| Sector | Industrials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 60.2M |
| IPO Year | N/A | 2018 |
| Metric | LSE | YI |
|---|---|---|
| Price | $4.63 | $6.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 28.8K | 14.4K |
| Earning Date | 02-13-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $61.76 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.80 | $2.48 |
| 52 Week High | $9.78 | $11.17 |
| Indicator | LSE | YI |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 40.62 |
| Support Level | $4.11 | $6.13 |
| Resistance Level | $5.43 | $6.86 |
| Average True Range (ATR) | 0.61 | 0.36 |
| MACD | -0.07 | -0.15 |
| Stochastic Oscillator | 0.42 | 24.64 |
Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.